36,800 Shares in Masimo Co. (NASDAQ:MASI) Acquired by Atika Capital Management LLC

Atika Capital Management LLC acquired a new position in Masimo Co. (NASDAQ:MASI - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 36,800 shares of the medical equipment provider's stock, valued at approximately $6,083,000. Atika Capital Management LLC owned 0.07% of Masimo as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in the business. BNP Paribas Financial Markets raised its stake in Masimo by 76.4% during the third quarter. BNP Paribas Financial Markets now owns 19,982 shares of the medical equipment provider's stock valued at $2,664,000 after buying an additional 8,656 shares during the last quarter. Verition Fund Management LLC bought a new stake in Masimo during the 3rd quarter valued at about $245,000. Centiva Capital LP bought a new position in shares of Masimo in the third quarter worth approximately $678,000. Stifel Financial Corp purchased a new stake in shares of Masimo during the third quarter valued at approximately $229,000. Finally, State Street Corp increased its position in shares of Masimo by 0.7% during the third quarter. State Street Corp now owns 1,438,814 shares of the medical equipment provider's stock valued at $191,837,000 after acquiring an additional 10,179 shares in the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Masimo

In other news, Director Craig B. Reynolds sold 2,053 shares of the stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $166.13, for a total value of $341,064.89. Following the completion of the sale, the director now directly owns 16,581 shares in the company, valued at $2,754,601.53. This represents a 11.02 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Bilal Muhsin sold 30,000 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the sale, the chief operating officer now owns 24,172 shares of the company's stock, valued at $4,048,568.28. This trade represents a 55.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 9.70% of the company's stock.

Wall Street Analysts Forecast Growth

MASI has been the subject of a number of research analyst reports. Piper Sandler lifted their target price on Masimo from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Wells Fargo & Company raised their price target on Masimo from $193.00 to $205.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. Raymond James upped their price objective on Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research note on Friday, December 27th. Finally, Needham & Company LLC restated a "hold" rating on shares of Masimo in a research note on Thursday. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $194.80.

Masimo Stock Performance

Shares of Masimo stock traded up $2.35 during trading on Friday, hitting $153.84. 218,707 shares of the company's stock were exchanged, compared to its average volume of 652,255. The stock has a market capitalization of $8.31 billion, a price-to-earnings ratio of 106.06 and a beta of 1.28. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01. The business has a 50-day simple moving average of $171.03 and a 200-day simple moving average of $164.13. Masimo Co. has a 52-week low of $101.61 and a 52-week high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last announced its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.38. The business had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Masimo had a return on equity of 14.98% and a net margin of 3.85%. On average, research analysts forecast that Masimo Co. will post 4.1 EPS for the current year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.